Next Steps for Cilta-Cel and CARTITUDE-4 in Multiple Myeloma
Binod Dhakal, MD, MS, discusses some of the next steps for evaluating ciltacabtagene autoleucel in multiple myeloma and the CARTITUDE-4 trial.
Related Articles
SBRT Is Feasible for Localized Prostate Cancer
Five-fraction SBRT was noninferior to radiotherapy in a phase 3 trial of patients with low- to intermediate-risk localized prostate cancer.
AE Profiles and Dosing Schedules Define the Role of CDK4/6 Inhibitors in HR+ Metastatic Breast Cancer
Kari Wisinski, MD, discusses factors that influence her decision between CDK4/6 inhibitors for patients with treatment-naive, HR+ metastatic breast cancer.
Dr Weiss on the Role of Breast Imaging in Breast Cancer Treatment Decision-Making
Anna Weiss, MD, discusses the significance of various imaging modalities in patients with breast cancer.
Dr Herbst on the Evolution of EGFR Inhibition in Lung Cancer
Roy S. Herbst, MD, PhD, discusses advances in EGFR inhibition throughout the past several decades in patients with lung cancer.
Btk inhibition: the importance of being selective
First generation Bruton’s tyrosine kinase (Btk) inhibitors were associated with both decreased thrombosis and increased bleeding. However, newer more selec
Publication Integrity Week 2024
We are delighted to announce Publication Integrity Week 2024. This week-long series of events will feature insights from across the publication integrity spectrum from sessions…
Cancer Knows No Borders: Utah and Nevada Joint Screening Event in Wendover
Mobile mammography buses from Huntsman Cancer Institute and Nevada Health Centers join forces to conquer distance as a disparity, offering Wendover residents vital breast cancer…
How AI Is Revolutionizing Oncology in Diagnosis, Treatment, and Research
In this episode of Targeted Talks, Douglas Flora, MD, LSSBB, FACCC, discusses the transformative impact of artificial intelligence in oncology.
FDA Approves Nilotinib Tablets Without Mealtime Restrictions for CML
The FDA has approved nilotinib tablets without mealtime restrictions for select patients with chronic myeloid leukemia.
The Best of CAR T at the 2024 Tandem Meetings Webinar Series
The following infographics are based on The Best of CAR T at the 2024 Tandem Meetings Webinar Series, which aired on June 27, 2024 and…
